Santa Monica:Antibiotics in Sepsis: Difference between revisions
(→Source) |
No edit summary |
||
| Line 6: | Line 6: | ||
##+/- fluconazole 400mg IV q24h | ##+/- fluconazole 400mg IV q24h | ||
#If allergy or prior exposure | #If allergy or prior exposure | ||
## aztreonam 2g IV q8h OR levofloxacin 750mg IV q24h | ## [[aztreonam]] 2g IV q8h OR levofloxacin 750mg IV q24h | ||
##+/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | ##+/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | ||
##+/- gentamicin 7mg/kg/dose IV q24h | ##+/- gentamicin 7mg/kg/dose IV q24h | ||
| Line 16: | Line 16: | ||
##AND, Azithromycin 500mg IV q24h | ##AND, Azithromycin 500mg IV q24h | ||
#If allergy or prior exposure | #If allergy or prior exposure | ||
##Levofloxacin 750mg IV q24h AND Aztreonam 2g IV q8h | ##Levofloxacin 750mg IV q24h AND [[Aztreonam]] 2g IV q8h | ||
==Pneumonia (Healthcare Assoc/Pseudomonas Risk)== | ==Pneumonia (Healthcare Assoc/Pseudomonas Risk)== | ||
| Line 34: | Line 34: | ||
## vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | ## vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | ||
#If allergy or prior exposure | #If allergy or prior exposure | ||
##aztreonam 2g IV q8h | ##[[aztreonam]] 2g IV q8h | ||
##AND, metronidazole 500mg IV q8h | ##AND, metronidazole 500mg IV q8h | ||
##+/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | ##+/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | ||
Revision as of 05:10, 27 February 2014
Unknown Source
- Primary Therapy
- piperacillin/tazobactam 4.5g IV q6h OR cefepime 1g IV q8h OR meropenem 1g IV q8h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- +/- gentamicin 7mg/kg/dose IV q24h
- +/- fluconazole 400mg IV q24h
- If allergy or prior exposure
- aztreonam 2g IV q8h OR levofloxacin 750mg IV q24h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- +/- gentamicin 7mg/kg/dose IV q24h
- +/- fluconazole 400mg IV q24h
Pneumonia (Community)
- Comm. Acquired
- Ceftriaxone 1g IV q24h
- AND, Azithromycin 500mg IV q24h
- If allergy or prior exposure
- Levofloxacin 750mg IV q24h AND Aztreonam 2g IV q8h
Pneumonia (Healthcare Assoc/Pseudomonas Risk)
- Primary therapy
- cefepime 1g IV q8h OR piperacillin/tazobactam 4.5g IV q6h
- +/- azithromycin 500mg IV q24h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- If allergy or prior exposure
- levofloxacin 750mg IV q24h
- +/- azithromycin 500mg IV q24h
- +/- gentamicin extended interval 7mg/kg/dose IV q24h
Abdominal/Pelvic
- Primary therapy
- piperacillin/tazobactam 4.5g IV q6h OR ertapenem 1g IV q24h OR ceftriaxone 1g IV q24h
- AND, metronidazole 500mg IV q8h
- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- If allergy or prior exposure
- aztreonam 2g IV q8h
- AND, metronidazole 500mg IV q8h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
Urosepsis
- Primary therapy
- ertapenem 1g IV q24h OR ceftriaxone 1g IV q24h
- If allergy or prior exposure
- ciprofloxacin 400mg IV q12h OR ciprofloxacin 400mg IV q12h
- AND, gentamicin 7mg/kg/dose IV q24h
Heme/Onch
- Primary therapy
- meropenem 1g IV q8h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- If allergy or prior exposure
- aztreonam 2g IV q8h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
See Also
Source
Santa-Monica UCLA 5/12
